Dr Nigel Whittle
With a biochemistry degree from Oxford and a PhD in the discovery of oncogenes, Nigel started work in the embryonic biotechnology industry to help bring some amazing discoveries into the clinic, first at Genentech Inc in the US, and then at Celltech and later Cantab Pharmaceuticals in the UK. He later set up his own successful life science consultancy before joining Plextek to build their medical and healthcare business, working with a range of talented people in innovative medical device organisations.
Latest articles
Virtual clinical trial recruits 67% faster led by NIHR Patient Recruitment Centre
A collaboration between one of the NIHR’s new National Patient Recruitment Centres (NPRCs) and UK sponsor company Enteromed has led to rapid recruitment to...
Cost of Russian Sputnik V vaccine for international markets to be less than $10...
The cost of the Russian Sputnik V vaccine for international markets will be less than $10 per dose starting from February 2021, making it...
R&D spending in the UK pharmaceutical sector has jumped 6.9% annually
Analysis of the latest ONS data by R&D tax relief specialists Catax shows that R&D spending in the UK pharmaceutical sector has jumped 6.9%...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Understanding the role of the MSL
Helen Kane surveyed more than 200 medical science liaisons (MSLs) to understand more about their current in-role reality. She gave Pf Magazine exclusive access...
Virtual clinical trial recruits 67% faster led by NIHR Patient Recruitment Centre
A collaboration between one of the NIHR’s new National Patient Recruitment Centres (NPRCs) and UK sponsor company Enteromed has led to rapid recruitment to...
Top 5 R&D hubs in the UK
Read this cover story in the June issue of Pf Magazine here. Join us on a tour of inspirational research and development centres. ...
Pancreatic Cancer Story: James Dadge
James, 44, lives in Manchester with his partner Andrea and sons Ben and Daniel. He was diagnosed with a neuroendocrine tumour, with the primary...